Published

    (DAG) Aquisição de serviços de desenvolvimento de novas funcionalidades no Portal Licenciamento+, do INFARMED, I.P. (PRR) (20260251)

    Notice number: 00721542-2026

    🇵🇹 PortugalServiços Partilhados do Ministério da Saúde, EPEServices

    KEY INFORMATION

    Submission deadline
    • Oct 26, 2026
    Location
    🇵🇹 Portugal
    Contracting authority
    Serviços Partilhados do Ministério da Saúde, EPE
    Accepted Languages
    Portuguese
    Tender type
    Services
    Contract Value
    Published date
    Oct 19, 2026

    TENDER DESCRIPTION

    This tender invites proposals for the development of new features on Infarmed, I.P.'s Licenciamento+ Portal, encompassing the implementation and validation of functional, non-functional, business, and technical requirements to deliver a robust, scalable, and secure technological solution. The project, with a total duration of 6 months for Phases 0 to VII, requires strict adherence to public administration usability and accessibility rules, including a declaration of accessibility. Key technical mandates include the use of Autenticacao.gov via the iAP platform for various authentication mechanisms (e.g., Cartão de Cidadão, CMD, eIDAS) and for consuming/providing webservices, alongside compliance with the National Digital Interoperability Regulation. Project methodology should cover governance, UI/UX, requirements, testing, training, knowledge transfer, risk management, and scope change management, ideally leveraging Agile/Scrum principles, while Infarmed will define the solution's architecture. Financial requirements include a 5% contractual guarantee (caução), with the first stage concluding by December 31, 2026, followed by 60 business days of post-production support and a…

    TENDER BRIEF

    The contract timeline is structured into several phases and stages with specific durations and milestones. The total duration for the project, encompassing Phases 0 to VII, is 6 months.

    The contract has the following key periods and milestones:

    • 1st Stage (releases 0 to 2): This stage begins on the business day following the contract's celebration date and concludes on December 31, 2026. This end date is linked to an extension of the execution period until December 31, 2026.
    • Release 0: Focuses on the planning and design of the future solution.
    • Release 1: Involves surveying indicators and implementing research.
    • Release 2: Pertains to "Pharmacies - 1 Form".
    • 2nd Stage (releases 3 to 6): This stage is scheduled to commence after the completion of Release 2.
    • Release 3: Covers "Distributors".
    • Release 4: Addresses "Direct Acquisition".
    • Release 5: Focuses on "Cannabis".
    • Release 6: Involves "Integration with INSP+".
    • 3rd Stage (Post-Production Phase): This phase starts after the conclusion of Release 6 and has a duration of 60 business days.
    • Post-Production Support: Following the project's conclusion, there is a post-production support phase funded by Infarmed, lasting 60 business days. A 6-month warranty period is also established after the project goes live.
    • Initial Project Activities: Phase 0 begins on the effective start date of the contract. A project kickoff meeting is required within 7 business days of the contract's effective start date. The actual project start date, to be agreed upon in this meeting, cannot be more than 8 business days after the meeting.

    The project is structured into distinct phases:

    • Fase 0: Initial Phase.
    • Fase I: Gathering of functional, non-functional, and technical requirements, including analysis and solution design.
    • Fase II: Development of the solution.
    • Fase III: Solution validation through testing.
    • Fase IV: Training.
    • Fase V: Knowledge transfer to the Contracting Public Entity Team.
    • Fase VI: Go-live.
    • Fase VII: Project conclusion.
    • Fase VIII: Warranty and post-production support.

    A high-level timeline is provided, which will be revised during Phase 0, and all deadlines for the different phases will be based on the schedule approved in Phase 0.

    Sources

    • 1CADERNO_ENCARGOS_INFARMED(PRR)_LIC+_20260251.pdf — “pelas diferentes fases acima identificadas. 4. Para cada release é efetuada a análise funcional, desenho técnico, desenvolvimento, testes, formação e divulgação ao exterior e entrada em produção. Todas estas atividades s…”

    The core scope of work for this tender primarily involves ensuring the implementation and validation of functional, non-functional, business, and technical requirements, and implementing a robust, scalable, and secure technological solution in accordance with defined standards and regulatory requirements.

    The Statement of Work (SOW) summary and core deliverables are structured across various phases and releases:

    Overall Objectives:

    • Assure the implementation and validation of functional, non-functional, business, and technical requirements, in compliance with applicable regulations and with express validation from the contracting entity.
    • Implement a robust, scalable, and secure technological solution, ensuring compliance with all technical, operational, regulatory, and security requirements defined in the Terms of Reference.

    Phase 0 Deliverables:

    • Project plan (including definition of releases and sprints).
    • High-level functional and technical design of the future solution.
    • Definition of processes that will be subject to team intervention, considering their impact on the market and Infarmed.
    • Definition of objectives to measure project success.
    • Detailed project plan and high-level survey of all needs.
    • Identification of licensing processes that will be subject to intervention by the project team, focusing on those with the greatest impact on the medicines and health products market.

    Transversal Activities Deliverables:

    • Weekly project report.
    • Monthly project report.
    • Meeting minutes for all meetings, sent to Infarmed for validation.

    Release 0 Deliverables (Planning and Design of the Future Solution):

    • Project plan.
    • Document with the macro solution definition.

    Release 1, 2, 3, 4, 5, 6 Deliverables:

    • User stories.
    • Technical design.
    • Code implementation.
    • Technical notebook and test log.
    • Application in production.

    Activities per Release (0 to VII):

    • Functional analysis.
    • Technical design.
    • Development.
    • Testing.
    • Training and external disclosure.
    • Go-live (entry into production).

    Any changes to the scope of the project must be documented, follow an established approval circuit between Infarmed and the service provider, and require written approval from Infarmed's project management, with no additional payments without such approval.

    Sources

    • 1CADERNO_ENCARGOS_INFARMED(PRR)_LIC+_20260251.pdf — “funcional e líder técnico tenham experiência na gestão/implementação de projetos com esta metodologia. 4. No presente documento são apresentadas as responsabilidades, fases, entregáveis e principais atividades do projeto…”

    Login to view all answers and insights

    Unlock tender brief for free

    TENDER DOCUMENTS

    DIRECTORY • 7 FILES

    • 419968303.pdf
    • espd-request.xml
    • README.txt

    Login to view and download all tender documents

    Unlock documents for free

    ASK AI ABOUT THIS TENDER

    You

    Can a foreign company apply?

    Riko

    Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.

    Login to ask more questions.

    Unlock AI tender chat for free

    Unlock your tender workflow

    Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.

    First monitor on Day 1All features included in trialNo credit card required

    You may also be interested in

    Similar tenders